Finance

Lists
301015:SHE
Qingdao Baheal Medical Inc
CNÂ¥26.50
+1.96%
(+0.51) 1D
Oct 13, 3:04:55 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301015...
Open
CNÂ¥25.73
High
CNÂ¥26.99
Low
CNÂ¥25.72
Mkt. cap
13.66B
Avg. vol.
6.67M
Volume
12.43M
Dividend
2.15%
Quarterly dividend
CNÂ¥0.14
Ex-dividend date
Jun 1, 2026
P/E ratio
26.17
52-wk high
CNÂ¥28.77
52-wk low
CNÂ¥18.40
EPS
CNÂ¥1.01
Shares outstanding
525.62M
No. of employees
2K
Open
CNÂ¥25.73
High
CNÂ¥26.99
Low
CNÂ¥25.72
Mkt. cap
13.66B
Avg. vol.
6.67M
Volume
12.43M
Dividend
2.15%
Quarterly dividend
CNÂ¥0.14
Ex-dividend date
Jun 1, 2026
P/E ratio
26.17
52-wk high
CNÂ¥28.77
52-wk low
CNÂ¥18.40
EPS
CNÂ¥1.01
Shares outstanding
525.62M
No. of employees
2K
News stories
From web sources and news partners
About Qingdao Baheal Medical Inc
CEO-
Employees2.49K
FoundedMar 8, 2005
Headquarters-
SectorHealth care provider
Websitebaheal.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.88B
1.88B
1.78B
1.78B
Cost of goods sold
1.10B
1.22B
1.08B
1.07B
Cost of revenue
1.10B
1.22B
1.08B
1.07B
Research and development expenses
8.32M
15.93M
5.19M
36.14M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
346.64M
651.14M
458.58M
490.05M
Operating expense
349.86M
696.59M
474.96M
537.04M
Total operating expenses
1.45B
1.91B
1.55B
1.61B
Operating income
421.15M
-34.46M
229.28M
167.00M
Other non operating income
-11.29M
9.69M
-3.76M
2.86M
EBT including unusual items
435.32M
27.69M
193.58M
144.56M
EBT excluding unusual items
391.96M
-43.82M
198.79M
135.30M
Income tax expense
86.11M
16.37M
38.12M
20.07M
Effective tax rate
19.78%
59.13%
19.69%
13.88%
Other operating expenses
-8.78M
28.01M
7.60M
15.06M
Net income
313.29M
-1.74M
123.94M
100.73M
Net profit margin
16.70%
-0.09%
6.95%
5.67%
Earnings per share
-
-
-
-
Interest and investment income
2.92M
20.73M
1.77M
2.01M
Interest expense
-28.49M
-26.92M
-28.50M
-29.52M
Net interest expenses
-25.57M
-6.18M
-26.73M
-27.51M
Depreciation and amortization charges
-
-
-
-
EBITDA
433.99M
-17.16M
246.58M
186.31M
Gain or loss from assets sale
1.80K
-520.33K
-
-181.18K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps